Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United Kingdom
/
Healthcare
/
ANGLE
AGL
ANGLE
Regulatory Scrutiny And Binary Deals Will Hinder Precision Medicine
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 3 Analysts
Published
17 Aug 25
Updated
17 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
UK£0.17
66.2% undervalued
intrinsic discount
17 Aug
UK£0.058
Loading
1Y
-57.8%
7D
9.5%
Author's Valuation
UK£0.2
66.2% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
UK£0.2
66.2% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-21m
10m
2014
2017
2020
2023
2025
2026
2028
Revenue UK£10.0m
Earnings UK£1.1m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
64.25%
Medical Equipment revenue growth rate
0.44%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
8.17%
Calculation
UK£1.10m
Earnings '28
x
63.12x
PE Ratio '28
=
UK£69.12m
Market Cap '28
UK£69.12m
Market Cap '28
/
321.53m
No. shares '28
=
UK£0.21
Share Price '28
UK£0.21
Share Price '28
Discounted to 2025 @ 8.20% p.a.
=
UK£0.17
Fair Value '25
